8Elsasser-Beile U, Buhler P, Wolf P. Targeted therapies for prostate cancer against the prostate specific membrane antigen. Current Drug Targets ,2009,10 : 118-125.
9Hernandez I, Maddison LA, Wei Y, et al. Prostate-specific expression of p53 (R172L) differentially regulates p21, Bax, and mdm2 to inhibit prostate cancer progression and prolong survival. Mol Cancer Res, 2003,1 : 1036-1047.
10Aden PM, Aden PM, Ono T, et al. Treatment efficiency of a suicide gene therapy using prostate-specific membrane antigen promoter/enhancer in a castrated mouse model of prostate cancer. Cancer Sci, 2004,95:367-370.
